Bank of New York Mellon
NPSP

Bank of New York Mellon’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bank of New York Mellon’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,827,186
Closed -$65.4M – 4317
2014
Q4 		$65.4M Buy
1,827,186
+38,461
+2% +$1.15M 0.02% 764
2014
Q3 		$46.5M Buy
1,788,725
+356,813
+25% +$10.2M 0.01% 910
2014
Q2 		$47.3M Sell
1,431,912
-107,889
-7% -$3.12M 0.01% 935
2014
Q1 		$46.1M Sell
1,539,801
-252,013
-14% -$8.69M 0.01% 946
2013
Q4 		$54.4M Buy
1,791,814
+99,829
+6% +$2.75M 0.02% 842
2013
Q3 		$53.8M Buy
1,691,985
+347,534
+26% +$7.97M 0.02% 821
2013
Q2 		$20.3M Buy
+1,344,451
New +$18.6M 0.01% 1370

Other funds holding NPSP

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon's NPSP Position: Q1 2015 in Review

Bank of New York Mellon sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 1,827,186 shares — an estimated $65.4M sold.

Bank of New York Mellon first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $65.4M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • Bank of New York Mellon reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Bank of New York Mellon sold 1,827,186 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $65.4M.
  • Bank of New York Mellon first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Bank of New York Mellon's NPS PHARMACEUTICALS INC position peaked at $65.4M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Bank of New York Mellon's 13F filing for Q1 2015, filed 13 May 2015.